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Purpose of the study
The number of pregnant patients with HIV in Glasgow has
increased over the past 3 years but is insufficient to justify
a dedicated HIV/antenatal clinic. Instead we enhanced a
multidisciplinary team approach to the care of HIV-posi-
tive pregnant women. We report our outcomes and key
learning from this experience.
Methods
Data were collected on all pregnancies occurring between
1 July 2005 and June 2008. Women already attending the
Brownlee Centre for their HIV care who became pregnant
and pregnant women found to be HIV- positive following
antenatal screening were included in the study. Antenatal
care was centralised mainly at Princess Royal Maternity,
Glasgow, and HIV care provided at the Brownlee Centre,
Glasgow. Monthly case management meetings were held
between centres. All cases were reviewed at annual audit
meetings.
Summary of results
There were 71 pregnancies resulting in 50 singleton deliv-
eries, nine miscarriages and 12 terminations. Black Afri-
can women constituted 57 (80%) of whom 32 were
asylum seekers, and 14 (20%) were Caucasian European.
Thirty-five women (49%) were diagnosed HIV-positive
following routine antenatal screening. Sixty-six (93%)
received HAART during pregnancy and in the five who did
not all had a spontaneous abortion or termination. Thirty
women were already on HAART at the time of conception
and of the 36 who commenced treatment during preg-
nancy the only indication in 24 of them was to reduce the
risk of mother-to-child transmission (MTCT). Of the 50
who delivered live infants, just eight (16%) had a detecta-
ble viral load at delivery. This was due to late diagnosis or
difficulty accepting the diagnosis with poor adherence.
Twenty-six (52%) delivered by Caesarean section and 24
(48%) had vaginal deliveries. Three women (6%) deliv-
ered at gestation <37 weeks. To date there has been no
MTCT and only one foetal abnormality (cleft lip and pal-
ate). The average birth weight was 3.09 kg (excluding a
pre-term infant of 780 g).
Conclusion
A significant proportion of pregnancies occurred within
our existing HIV cohort, most of these women conceiving
on HAART. In centres without sufficient numbers to run
dedicated antenatal/HIV clinics, it is possible to obtain
good results through close team working. There was no
increased rate of pre-term delivery and no increased risk of
low birth-weight. Non-adherence was the most important
factor in failing to achieve undetectable viral load at deliv-
ery.
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